Physician profile
David Tannenbaum
NPI 1043216443
$386.58
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $335 · 2023: $27.05 · 2024: $24.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $51.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $51.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $63.48 | 2019 | |
| Millicent US INC | $53.54 | 2019 | |
| Amag Pharmaceuticals, INC. | $39.20 | 2019 | |
| Therapeuticsmd, INC. | $37.34 | 2019 | |
| Ethicon US, LLC | $32.77 | 2019 | |
| Hologic Sales and Service, LLC | $28.62 | 2019-2024 | Aptima |
| Axonics, INC. | $27.05 | 2023 | Axonics |
| Duchesnay USA Incorporated | $17.85 | 2019 | |
| Allergan, INC. | $14.72 | 2019 | |
| Merck Sharp & Dohme LLC | $14.19 | 2019 | |
| Amgen INC. | $13.09 | 2019 | |
| Avion Pharmaceuticals | $12.84 | 2019 | |
| Lupin INC. | $12.37 | 2019 | |
| Exeltis, USA INC. | $11.57 | 2019 | |
| Organon LLC | $7.95 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Tannenbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.